Portfolio company
Nurix Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops targeted protein degradation therapies to treat patients with cancer and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Plexium
This company develops targeted protein degradation therapeutics and discovery platforms for patients with cancer and neurodegenerative diseases.
Amphista Therapeutics
This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.
Arvinas
This biopharmaceutical company develops protein degradation therapies to treat patients with cancer and neurodegenerative diseases.
ProteoValent Therapeutics
This company develops targeted protein degrader therapies for cancer and haematology patients.
Biotheryx
The company develops protein degrader medicines for patients with cancer and inflammatory diseases.
Autolus Therapeutics
This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.